0000950170-23-041593 Sample Contracts

SECOND AMENDMENT TO ONCOSIGNATURE COMPANION DIAGNOSTIC AGREEMENT

Oncosignature Companion Diagnostic Agreement • August 11th, 2023 • Acrivon Therapeutics, Inc. • Pharmaceutical preparations

• Contract Type
  Oncosignature Companion Diagnostic Agreement
• Filed
  August 11th, 2023
• Company
  Acrivon Therapeutics, Inc.
• Industry
  Pharmaceutical preparations

This Second Amendment to Oncosignature Companion Diagnostic Agreement (the “Second Amendment”) is made and entered into as of June 19, 2023 (the “Second Amendment Effective Date”) by and between: